The Experts below are selected from a list of 31857 Experts worldwide ranked by ideXlab platform
Yoshinobu Onuma - One of the best experts on this subject based on the ideXlab platform.
-
tct 176 implantation of thin strut sirolimus eluting bioresorbable vascular scaffold in patients with de novo coronary Artery Lesions 2 year clinical and 6 month imaging outcomes of the meres 1 extend trial
Journal of the American College of Cardiology, 2019Co-Authors: Alexandre Abizaid, Sasko Kedev, Rosli Mohd Ali, Teguh Santoso, Angel Cequier, R J Van Geuns, Bernard Chevalier, Farrel Hellig, Ricardo A Costa, Yoshinobu OnumaAbstract:The development of bioresorbable vascular scaffold (BRS) offers a new treatment strategy for coronary Artery Lesion by replacement of a permanent metallic scaffold with a temporary scaffold and eradicating a nidus for very late adverse events. The first-in-human MeRes-1 trial reported favorable
-
tct 64 two year clinical and imaging outcomes of thin strut sirolimus eluting bioresorbable vascular scaffolds in de novo coronary Artery Lesions the meres 1 trial
Journal of the American College of Cardiology, 2018Co-Authors: Ashok Seth, Ricardo A Costa, Yoshinobu Onuma, Praveen Chandra, V K Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar U Mahajan, Viveka Kumar, Parvin Kumar Goel, Gurpreet Singh WanderAbstract:The development of fully bioresorbable vascular scaffolds (BRS) offers a new intervention strategy for coronary Artery Lesion by replacement of “full-metal jacket” into “full-plastic jacket”. The aim of the present study was to assess the long-term safety and performance of thin strut
Ricardo A Costa - One of the best experts on this subject based on the ideXlab platform.
-
tct 176 implantation of thin strut sirolimus eluting bioresorbable vascular scaffold in patients with de novo coronary Artery Lesions 2 year clinical and 6 month imaging outcomes of the meres 1 extend trial
Journal of the American College of Cardiology, 2019Co-Authors: Alexandre Abizaid, Sasko Kedev, Rosli Mohd Ali, Teguh Santoso, Angel Cequier, R J Van Geuns, Bernard Chevalier, Farrel Hellig, Ricardo A Costa, Yoshinobu OnumaAbstract:The development of bioresorbable vascular scaffold (BRS) offers a new treatment strategy for coronary Artery Lesion by replacement of a permanent metallic scaffold with a temporary scaffold and eradicating a nidus for very late adverse events. The first-in-human MeRes-1 trial reported favorable
-
tct 64 two year clinical and imaging outcomes of thin strut sirolimus eluting bioresorbable vascular scaffolds in de novo coronary Artery Lesions the meres 1 trial
Journal of the American College of Cardiology, 2018Co-Authors: Ashok Seth, Ricardo A Costa, Yoshinobu Onuma, Praveen Chandra, V K Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar U Mahajan, Viveka Kumar, Parvin Kumar Goel, Gurpreet Singh WanderAbstract:The development of fully bioresorbable vascular scaffolds (BRS) offers a new intervention strategy for coronary Artery Lesion by replacement of “full-metal jacket” into “full-plastic jacket”. The aim of the present study was to assess the long-term safety and performance of thin strut
Gurpreet Singh Wander - One of the best experts on this subject based on the ideXlab platform.
-
tct 64 two year clinical and imaging outcomes of thin strut sirolimus eluting bioresorbable vascular scaffolds in de novo coronary Artery Lesions the meres 1 trial
Journal of the American College of Cardiology, 2018Co-Authors: Ashok Seth, Ricardo A Costa, Yoshinobu Onuma, Praveen Chandra, V K Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar U Mahajan, Viveka Kumar, Parvin Kumar Goel, Gurpreet Singh WanderAbstract:The development of fully bioresorbable vascular scaffolds (BRS) offers a new intervention strategy for coronary Artery Lesion by replacement of “full-metal jacket” into “full-plastic jacket”. The aim of the present study was to assess the long-term safety and performance of thin strut
Masahiko Shibuya - One of the best experts on this subject based on the ideXlab platform.
-
effect of bare metal nitinol stent implantation and paclitaxel eluting nitinol stent implantation on vascular response in the superficial femoral Artery Lesion assessed on intravascular ultrasound
Circulation, 2014Co-Authors: Kojiro Miki, Kenichi Fujii, Daizo Kawasaki, Masashi Fukunaga, Machiko Nishimura, Tetsuo Horimatsu, Ten Saita, Hiroto Tamaru, Takahiro Imanaka, Masahiko ShibuyaAbstract:Background: Although previous intravascular ultrasound (IVUS) studies reported that the drug-eluting stent (DES) has successfully decreased in-stent restenosis (ISR) by inhibiting neointimal hyperplasia (NIH) in the coronary Artery Lesion, no IVUS data for vascular response after DES implantation in the superficial femoral Artery (SFA) have been published. Methods and Results: We retrospectively analyzed 38 de novo SFA Lesions from 32 patients who underwent endovascular therapy (EVT) with self-expanding bare-metal nitinol stent (25 Lesions; BMS group) or self-expanding paclitaxel-eluting nitinol stents (13 Lesions; PES group). At 6 months after EVT, follow-up IVUS was done to evaluate NIH. Serial IVUS volumetric analysis was done after stent deployment and at follow-up. Mean stent, lumen and neointimal areas were calculated as the volume divided by the stent length. The primary endpoint of this study was mean late lumen loss at 6-month follow-up. The mean follow-up period was 189±39 days. Mean neointimal area was smaller in the PES group compared to the BMS group (3.3±1.0mm2 vs. 10.2±4.1mm2, P<0.001). Mean late lumen loss was significantly lower in the PES group compared to the BMS group (−2.3±3.7mm2 vs. 2.1±4.7mm2, P<0.05). Conclusions: EVT with DES in SFA Lesions might decrease NIH associated with ISR in short-term follow-up. (Circ J 2014; 78: 1451–1458)
Marie-lucebochaton-piallat - One of the best experts on this subject based on the ideXlab platform.
-
Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion
Arteriosclerosis Thrombosis and Vascular Biology, 2006Co-Authors: Hiroyukihao, Giuliogabbiani, Edoardocamenzind, Marcbacchetta, Renuvirmani, Marie-lucebochaton-piallatAbstract:Objectives— Characterize the phenotypic features of media and intima coronary Artery smooth muscle cells (SMCs) in mildly stenotic plaques, erosions, stable plaques, and in-stent restenosis. Methods and Results— Expression of α-smooth muscle actin (α-SMA), smooth muscle myosin heavy chains (SMMHCs), and smoothelin was investigated by immunohistochemistry followed by morphometric quantification. The cross-sectional area and the expression of cytoskeletal proteins in the media were lower in restenotic Lesions and, to a lesser extent, in stable plaques compared with mildly stenotic plaques and erosions. An important expression of α-SMA was detected in the intima of the different Lesions; moreover, α-SMA staining was significantly larger in erosions compared with all other conditions. In the same location, a striking decrease of SMMHCs and a disappearance of smoothelin were observed in all situations. Conclusions— Medial atrophy is prevalent in restenotic Lesions and stable plaques compared with mildly stenot...
